A Safety, Tolerability and Efficacy Study of TransCon hGH in Children With Growth Hormone Deficiency

Clinical trial NCT03305016 · COMPLETED

Trial details

NCT number: NCT03305016
Sponsor: Ascendis Pharma Endocrinology Division A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Growth Hormone Deficiency, Pediatric Endocrine System Diseases Hormone Deficiency Pituitary Diseases

Start date: 2017-11-13
Primary completion: 2019-03-19
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.